Napo reports positive results from diarrhoea drug study
The randomised, placebo-controlled, multi-centre study was conducted by Glenmark Pharmaceuticals, the partner of Napo Pharmaceuticals. The study results showed that patients receiving crofelemer had significantly higher resolution of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.